Mark E. Jones, PhD

Basilea Pharmaceutica International Ltd., Allschwil, Switzerland
Allschwil,, Basel-Landschaft, Switzerland

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• 1124 - Safety and Outcomes of Isavuconazonium Sulfate for the Treatment of Invasive Aspergillosis or Invasive Mucormycosis in Pediatric Patients

  Friday, October 13, 2023
  12:35 PM – 12:40 PM US ET

• 1946 - In Vitro Activity of Ceftobiprole against Staphylococcus aureus Bacteremia Isolates from the United States (2018–2020)

  Friday, October 13, 2023
  2:00 PM – 2:15 PM US ET